SCHEMBL4183069

SCHEMBL4183069

COC(=O)Cc1cc(O)cc(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.61
ALDH1A1 P00352 3/20 0.39
GAA P10253 2/20 0.39
GFER P55789 1/20 0.39
DRD2 P14416 1/20 0.37
PREP P48147 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
CALM1 P0DP23 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
TP53 P04637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
RPS6KB2 Q9UBS0 1/20 0.34
CA12 O43570 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188131 0.82 HSP90AB1 (0.39) HSP90AB1ALDH1A1GAAGFERDRD2
SCHEMBL9340684 0.82 SLC7A5 (0.49) HSP90AB1ALDH1A1GAAGFERDRD2
SCHEMBL4184054 0.81 HSP90AB1 (0.38) HSP90AB1ALDH1A1GAAGFERDRD2
SCHEMBL3839217 0.81 CYP4F2 (0.50) HSP90AB1ALDH1A1GAAGFERDRD2
SCHEMBL2977953 0.80 HSP90AB1 (0.76) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL1525541 0.79 HSP90AB1 (0.52) HSP90AB1ALDH1A1GAAGFERNPC1
SCHEMBL27742563 0.78 ALDH1A1 (0.40) HSP90AB1ALDH1A1DRD2PREPCALM1
SCHEMBL8151711 0.78 HSP90AB1 (0.92) HSP90AB1ALDH1A1GAAGFERNPC1
SCHEMBL478058 0.78 HSP90AB1 (1.00) HSP90AB1ALDH1A1GAAGFERNPC1
SCHEMBL9202392 0.76 HSP90AB1 (0.69) HSP90AB1ALDH1A1GAAGFERNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-07-30 US disclosed
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-07-30 US disclosed
US-20080292608-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2008-11-27 US disclosed
US-20080292608-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2008-11-27 US disclosed
EP-1945620-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2008-07-23 EP disclosed
WO-2007056366-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080292608-A1 Compounds and Compositions as Ppar Modulators PPARG, PPARA, PPARD HSP90AB1 1028/4885ALDH1A1 1696/4885GAA 995/4885
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS PPARG, PPARA, PPARD HSP90AB1 1028/4885ALDH1A1 1696/4885GAA 995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.